Down to $6.5m market cap , One can only keep accumulating in this environment.
Intrepid - Phase II trial for TBI (fully funded)
http://www.neurenpharma.com/ssl/CMS/files_cms/Arrowhead%20TBI%20Conference%20NNZ2566%20Presentation.pdf
Motiva - Phase II trial for Post Stroke Apathy (fully funded)
http://www.asx.net.au/asxpdf/20100303/pdf/31p1qnxh4rctvw.pdf
Perseis - Currently selecting antibodies from preclinical trials (seeking collaboration to accelerate development)
http://www.neurenpharma.com/ssl/CMS/files_cms/Perseis%20Overview%20Mar11.pdf
neu comparison vs other biotechs, page-2
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.25 |
Change
-0.360(2.65%) |
Mkt cap ! $1.692B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.20 | $1.190M | 89.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 709 | $13.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.28 | 646 | 5 |
View Market Depth
| Last trade - 10.47am 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |